Oncopharmpod

P1: Tamoxifen for Breast Cancer Risk Reduction

Informações:

Synopsis

The Landmarks in Oncology Pharmacy series returns with the P1 study. We review this landmark paper paving the way for breast cancer risk reduction (or chemoprevention) and discuss the mark or lack thereof (frown emoji) it has made in clinical practice.